<DOC>
<DOCNO>
EP-0002533
</DOCNO>
<TEXT>
<DATE>
19790627
</DATE>
<IPC-CLASSIFICATIONS>
<main>A61K-31/215</main> A61K-31/165 A61K-31/215 A61K-31/045 A61K-31/21 A61K-31/07 
</IPC-CLASSIFICATIONS>
<TITLE>
use of retinoids as medicines.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
bollag werner dr<sep>reber kurt dr<sep>bollag, werner, dr.<sep>reber, kurt, dr.<sep>bollag, werner, dr.mythenstrasse 10ch-4054 baselch<sep>reber, kurt, dr.eigenweg 42ch-4107 ettingench<sep>bollag, werner, dr.  <sep>reber, kurt, dr. <sep>bollag, werner, dr.mythenstrasse 10ch-4054 baselch<sep>reber, kurt, dr.eigenweg 42ch-4107 ettingench<sep>
</INVENTOR>
<ABSTRACT>
Use of retinoids, in particular of the 9- (4-methoxy-2,3,6-trimethylphenyl) -3.7-dimethyl-Nona-2,4,6,8-tetraen-1-acid-ethyl ester, for oral treatment rheumaticDiseases.
</ABSTRACT>
</TEXT>
</DOC>
